Epitalon (AEDG) — pineal tetrapeptide longevity research
Epitalon is the most-studied member of the “short peptide bioregulator” family that came out of the St Petersburg gerontology school. It is a four-residue synthetic peptide — Ala-Glu-Asp-Gly, or AEDG — designed from the amino-acid composition of a bovine pineal-gland extract called Epithalamin. The published pharmacology is concentrated on geroprotection: telomerase activity in cultured cells, modulation of melatonin and neuroendocrine rhythms, and a long series of rodent life-span and spontaneous-tumour studies. The animal-model record is substantial; the human clinical record is thin.
What Epitalon actually is
Epitalon is a synthetic tetrapeptide with the primary sequence Ala-Glu-Asp-Gly (single-letter AEDG), molecular weight approximately 390 Da. It was synthesised from the amino-acid composition of Epithalamin, a peptide preparation originally extracted from the bovine pineal gland and studied by Vladimir Khavinson, Vladimir Anisimov and colleagues at the St Petersburg Institute of Bioregulation and Gerontology. The switch from a tissue extract (Epithalamin) to a defined four-residue synthetic peptide (Epitalon) is what made reproducible, purity-controlled research possible.
The 2025 review by Araj and colleagues in the International Journal of Molecular Sciences — the most comprehensive recent synthesis of the literature — describes Epitalon as a “highly bioactive pineal tetrapeptide” whose 25 years of in-vitro, in-vivo and in-silico study point to geroprotective and neuroendocrine effects, while explicitly noting that the precise mechanism remains uncertain [1].
What the mechanism research shows
The peer-reviewed findings cluster into three areas:
- Telomerase activity. In-vitro work reports that Epitalon increases telomerase activity in cultured human somatic cells, allowing additional population doublings before replicative senescence. The Araj 2025 review consolidates telomerase enhancement among the documented enzymatic effects, alongside effects on acetylcholinesterase and butyrylcholinesterase [1]. Telomerase induction in culture is a real signal — but it is not the same as a demonstrated life-extension effect in humans.
- Neuroendocrine / melatonin modulation. Because Epitalon descends from a pineal preparation, much of the research examines its influence on melatonin synthesis and circadian-rhythm signalling, with reported effects on the mRNA levels of signalling molecules such as interleukin-2 and on thymocyte mitogenic activity [1].
- Geroprotection in rodent models. The St Petersburg group reported that Ala-Glu-Asp-Gly administration increased mean life span and reduced spontaneous-tumour incidence in rodents, with the magnitude depending on the light-exposure regime the animals were kept under [2]. A separate study reported an inhibitory effect on chemically-induced colon carcinogenesis in rats — a carcinogenesis-research finding, not a treatment claim [3].
Honest take: Epitalon has one of the deeper preclinical records in the longevity-peptide category — but almost all of it traces to a single research lineage, and the leap from cultured-cell telomerase and rodent life-span data to human outcomes is exactly the leap the published record has not yet made.
Where it sits in the Khavinson bioregulator family
Epitalon is the flagship of a wider set of short peptide bioregulators studied by the same group — each a di-, tri- or tetrapeptide associated with a specific tissue. Our companion overview of the Khavinson bioregulators covers the class as a whole and the “peptide bioregulation” hypothesis behind it. The thymic peptide Thymalin is the immune-system counterpart most often studied alongside the pineal peptides. For the broader UAE research-sourcing picture, see the research peptides in the UAE overview.
The UAE research-supply landscape
Epitalon is supplied in the UAE as a lyophilised powder, commonly in 10 mg and higher-capacity 50 mg research vials. Because it is a short, water-soluble peptide with no disulphide bridges, it is comparatively easy to synthesise and reconstitute — which paradoxically makes purity verification more important, not less, because low barriers to manufacture mean wide quality variance across vendors.
Open questions
What the published literature has not resolved:
- Independent replication. Most of the geroprotection and life-span data comes from one research lineage; broad independent replication outside that group is limited.
- Human translation. The rodent life-span findings have no equivalent randomised human trial, and telomerase induction in culture is not a validated surrogate for human longevity.
- Mechanism. Whether the documented effects flow from a single receptor interaction, direct gene-regulatory binding, or several parallel pathways is, per the 2025 review, still unsettled.
- Pharmacokinetics. The absorption, distribution and metabolism of such a small peptide in humans are poorly described in the public record.
Epitalon research cluster — deeper dives
Three companion deep-dives go under this overview, each on one axis of the Epitalon record:
- Epitalon mechanism research — how a four-residue peptide could act: telomerase enzymology in cultured cells, the direct promoter-binding hypothesis, epigenetic and differentiation effects, the melatonin lineage, and why the mechanism is still open.
- Epitalon longevity and telomerase research — how strong the geroprotection evidence is, graded as an evidence ladder from cultured cells to invertebrates to rodents — and the missing human rung.
- Epitalon dosing research protocols — the dose figures the published literature actually used (descriptively, not as a protocol), reconstitution and syringe math, storage, and why circulating “cycles” are convention rather than validated dose.
Further reading
Peer-reviewed citations used inline:
- [1] Araj, Brzezik, et al. — Int J Mol Sci 2025. “Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties.” DOI 10.3390/ijms26062691.
- [2] Vinogradova, Anisimov, et al. — Bull Exp Biol Med 2007. Effect of Ala-Glu-Asp-Gly on life span and spontaneous tumours in rats under different illumination regimes. DOI 10.1007/s10517-007-0441-z.
- [3] Anisimov, et al. — Cancer Lett 2002. Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. DOI 10.1016/s0304-3835(02)00090-3.
Last reviewed 11 June 2026. Wellness Labs supplies Epitalon as research-grade lyophilised powder for non-clinical investigation. Editorial inbox: info@uaewellnesslab.com.
Frequently asked questions
- What is Epitalon?
- Epitalon (also spelled Epithalon or Epithalone) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, abbreviated AEDG. It was designed from the amino-acid composition of Epithalamin, a peptide preparation extracted from the bovine pineal gland and studied by the St Petersburg gerontology group from the 1980s. In published research it is classed as a pineal bioregulator and studied for geroprotective and neuroendocrine effects. It is supplied research-grade as a lyophilised powder for non-clinical investigation, most often in 10 mg and 50 mg vials.
- Does Epitalon activate telomerase?
- Several in-vitro studies report that Epitalon increases telomerase activity in cultured human somatic cells, and a 2025 review in the International Journal of Molecular Sciences consolidates telomerase enhancement among its documented enzymatic effects alongside effects on melatonin synthesis and immune-cell signalling. Important caveat: telomerase induction in cultured cells does not by itself establish a life-extension effect in humans, and the review notes the full mechanism remains incompletely characterised. The human clinical evidence is far thinner than the cell-culture and rodent literature.
- What did the rodent life-span studies show?
- The St Petersburg group (Anisimov, Vinogradova and colleagues) ran a series of rodent studies reporting that Ala-Glu-Asp-Gly administration was associated with increased mean life span and a reduced incidence of spontaneous tumours, with the effect varying by light-exposure regime. These are animal-model findings published in Bull Exp Biol Med and related journals. They are scientifically interesting but do not translate directly to humans — there is no equivalent randomised human life-span trial.
- Is Epitalon the same as Epithalamin?
- No. Epithalamin is the original peptide complex extracted from bovine pineal tissue. Epitalon (AEDG) is the short synthetic tetrapeptide designed from Epithalamin’s amino-acid composition, so it can be manufactured to a defined sequence and purity rather than as a tissue extract. Most modern research uses the defined synthetic AEDG tetrapeptide.
- How is research-grade Epitalon stored and reconstituted?
- Epitalon is supplied as a lyophilised (freeze-dried) powder, stable for extended periods at -20°C protected from light. For research use it is reconstituted with bacteriostatic water; once reconstituted it is typically held at 2-8°C and used within about 28 days. Because it is a small four-residue peptide, handling is straightforward, but a third-party HPLC purity assay and mass-spec identity confirmation on the batch COA are the markers of a serious research-grade supply.
- Is Epitalon approved as a medicine?
- No. Epitalon has not been approved as a medicine by the FDA, EMA, or equivalent regulators. The bulk of the evidence is in-vitro and rodent work from a single research lineage, with limited independent human data. It is supplied for research use only — not for human consumption — and all longevity-related claims are extrapolations from preclinical models rather than conclusions from human randomised trials.